![]() |
市場調查報告書
商品編碼
1399716
檢體採集卡市場 - 副產品(基於棉花和纖維素、纖維為基礎)、檢體(血液、唾液、尿液)、應用(傳染病檢測、新生兒篩檢)、最終用途 - 全球預測,2023-2032 年Specimen Collection Cards Market - By Product (Cotton & Cellulose-based, Fiber-based), Specimen (Blood, Saliva, Urine), Application (Infectious Disease Testing, Newborn Screening), End-use - Global Forecast, 2023-2032 |
由於對高效診斷程序的日益重視,預計 2023 年至 2032 年標本採集卡市場的CAGR將達到 5%。樣本採集卡能夠簡化樣本採集、運輸和存儲,有助於簡化診斷流程。這在醫療保健環境中尤其重要,因為快速且準確的樣本採集對於及時診斷和治療至關重要。
該產品可用於保存 DNA、RNA 或蛋白質以進行分子測試,使其在研究和診斷實驗室中不可或缺。各種疾病的分子診斷技術的日益採用推動了市場需求。 2022 年 6 月,生物研究完整樣品保護的領導者 GenTegra LLC 推出了 RNAdvantage,這是其套件中最新的 RNA 穩定產品。透過此次推出,GenTegra 產品可以穩定和保護新鮮組織樣本和純化液體 RNA 中有價值的 RNA。
全球標本採集卡產業根據產品類型、標本類型、應用、最終用途和地區進行細分。
由於纖維在樣品保存和運輸方面的優勢,預計到 2032 年,基於纖維的細分市場將獲得動力並以強勁的CAGR成長。這些卡片為標本儲存提供了穩定的環境,防止核酸分解並確保生物樣本的完整性。此外,纖維基材料的環保特性與人們對永續和可生物分解產品的日益重視相一致,從而滿足了產品需求。
由於樣本採集的便利性和非侵入性,尿液細分市場將在 2023 年和 2032 年顯著成長。專為尿液樣本設計的卡提供了一種方便用戶使用的方法來收集和保存樣本,無需專門的設備或侵入性操作。這種簡單性使得它們在各種診斷應用中特別有吸引力,包括藥物測試、懷孕測試和疾病監測。易於使用,加上能長時間穩定尿液樣本的能力,將有利於樣本採集卡的使用。
在慢性病盛行率不斷上升和對預防性醫療保健日益關注的支持下,歐洲標本採集卡產業規模將在 2023 年和 2032 年顯著成長。個人化醫療和分子診斷的進步進一步推動了產品需求,特別是在基因組學和傳染病檢測等應用中。歐洲醫療保健產業嚴格的法規和品質標準強調了可靠和標準化樣本收集方法的重要性,從而刺激了區域市場的成長。
Specimen Collection Cards Market is estimated to observe 5% CAGR from 2023 to 2032, driven by increasing emphasis on efficient diagnostic procedures. Specimen collection cards, with their ability to simplify sample collection, transport, and storage, contribute to streamlined diagnostic processes. This is particularly crucial in healthcare settings where quick and accurate sample collection is essential for timely diagnosis and treatment.
The product finds application in preserving DNA, RNA, or proteins for molecular testing, making it indispensable in research and diagnostic laboratories. The growing adoption of molecular diagnostic techniques for various diseases fuels the market demand. In June 2022, GenTegra LLC, a leader of complete sample protection for biological research, launched RNAdvantage, the latest RNA stabilization products in their suite. With this launch, GenTegra products can stabilize and protect valuable RNA in fresh tissue samples and purified liquid RNA.
The worldwide specimen collection cards industry is segmented based on product type, specimen type, application, end-use, and region.
Fiber-based segment is anticipated to gain momentum and grow at a strong CAGR through 2032, owing to its advantages in sample preservation and transportation. These cards provide a stable environment for specimen storage, preventing degradation of nucleic acids and ensuring the integrity of biological samples. Additionally, the eco-friendly nature of fiber-based materials aligns with the increasing emphasis on sustainable and biodegradable products, contributing to the product demand.
Urine segment will record notable growth during 2023 and 2032, due to the convenience and non-invasive nature in sample collection. The cards designed for urine samples provide a user-friendly method for collecting and preserving specimens without the need for specialized equipment or invasive procedures. This simplicity makes them particularly attractive in various diagnostic applications, including drug testing, pregnancy testing, and disease monitoring. The ease of use, coupled with the ability to stabilize urine samples for extended periods, will favor the usage of specimen collection cards.
Europe specimen collection cards industry size will witness significant growth throughout 2023 and 2032, backed by the increasing prevalence of chronic diseases and the rising focus on preventive healthcare. The advancements in personalized medicine and molecular diagnostics further fuel the product demand, especially in applications including genomics and infectious disease testing. Stringent regulations and quality standards in the European healthcare sector underscore the importance of reliable and standardized sample collection methods, stimulating the regional market growth.